Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mari Malkki

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Gynecologic Oncology|December 3, 2011
Genetic variation in CD83 and risks of cervical and vulvar cancers: a population-based case-control studyClara Bodelon, Margaret M Madeleine, Lisa G Johnson, et al.
International Journal of Molecular Epidemiology and Genetics|December 10, 2013
Common sequence variants in chemokine-related genes and risk of breast cancer in post-menopausal womenClara Bodelon, Katheleen E Malone, Lisa G Johnson, et al.
Blood|April 22, 2026
Extended HLA Haplotypes and Transplant SurvivalEffie W Petersdorf, Caroline McKallor, Mari Malkki, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 13, 2010
Risk of cervical cancer associated with allergies and polymorphisms in genes in the chromosome 5 cytokine clusterLisa G Johnson, Stephen M Schwartz, Mari Malkki, et al.
Breast Cancer Research and Treatment|April 28, 2011
Genetic variation in proinflammatory cytokines IL6, IL6R, TNF-region, and TNFRSF1A and risk of breast cancerMargaret M Madeleine, Lisa G Johnson, Mari Malkki, et al.
BMC Cancer|May 3, 2013
Genetic variation in TLR or NFkappaB pathways and the risk of breast cancer: a case-control studyAlexa J Resler, Kathleen E Malone, Lisa G Johnson, et al.
Science Translational Medicine|July 28, 2012
MHC-resident variation affects risks after unrelated donor hematopoietic cell transplantationEffie W Petersdorf, Mari Malkki, Theodore A Gooley, et al.
Blood|February 4, 2010
Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantationJeffrey M Venstrom, Ted A Gooley, Stephen Spellman, et al.
Gynecologic Oncology|August 5, 2015
A population-based case-control study of genetic variation in cytokine genes associated with risk of cervical and vulvar cancersSheetal Hardikar, Lisa G Johnson, Mari Malkki, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2009
What is the role for donor natural killer cells after nonmyeloablative conditioning?Frédéric Baron, Effie W Petersdorf, Ted Gooley, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Gynecologic Oncology|December 3, 2011
Genetic variation in CD83 and risks of cervical and vulvar cancers: a population-based case-control studyClara Bodelon, Margaret M Madeleine, Lisa G Johnson, et al.
International Journal of Molecular Epidemiology and Genetics|December 10, 2013
Common sequence variants in chemokine-related genes and risk of breast cancer in post-menopausal womenClara Bodelon, Katheleen E Malone, Lisa G Johnson, et al.
Blood|April 22, 2026
Extended HLA Haplotypes and Transplant SurvivalEffie W Petersdorf, Caroline McKallor, Mari Malkki, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 13, 2010
Risk of cervical cancer associated with allergies and polymorphisms in genes in the chromosome 5 cytokine clusterLisa G Johnson, Stephen M Schwartz, Mari Malkki, et al.
Breast Cancer Research and Treatment|April 28, 2011
Genetic variation in proinflammatory cytokines IL6, IL6R, TNF-region, and TNFRSF1A and risk of breast cancerMargaret M Madeleine, Lisa G Johnson, Mari Malkki, et al.
BMC Cancer|May 3, 2013
Genetic variation in TLR or NFkappaB pathways and the risk of breast cancer: a case-control studyAlexa J Resler, Kathleen E Malone, Lisa G Johnson, et al.
Science Translational Medicine|July 28, 2012
MHC-resident variation affects risks after unrelated donor hematopoietic cell transplantationEffie W Petersdorf, Mari Malkki, Theodore A Gooley, et al.
Blood|February 4, 2010
Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantationJeffrey M Venstrom, Ted A Gooley, Stephen Spellman, et al.
Gynecologic Oncology|August 5, 2015
A population-based case-control study of genetic variation in cytokine genes associated with risk of cervical and vulvar cancersSheetal Hardikar, Lisa G Johnson, Mari Malkki, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2009
What is the role for donor natural killer cells after nonmyeloablative conditioning?Frédéric Baron, Effie W Petersdorf, Ted Gooley, et al.
Pageof 5